What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?

On September 18, 2007, a collaborative session between the International Society for CNS Clinical Trials and Methodology and the International Society for CNS Drug Development was held in Brussels, Belgium. Both groups, with membership from industry, academia, and governmental and nongovernmental ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemp, Aaron S., Schooler, Nina R., Kalali, Amir H., Alphs, Larry, Anand, Ravi, Awad, George, Davidson, Michael, Dubé, Sanjay, Ereshefsky, Larry, Gharabawi, Georges, Leon, Andrew C., Lepine, Jean-Pierre, Potkin, Steven G., Vermeulen, An
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Regular Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879679/
https://www.ncbi.nlm.nih.gov/pubmed/18723840
http://dx.doi.org/10.1093/schbul/sbn110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879679/
https://www.ncbi.nlm.nih.gov/pubmed/18723840
http://dx.doi.org/10.1093/schbul/sbn110

Ejemplares similares